These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

633 related items for PubMed ID: 25634851

  • 1. Drug treatment of obesity: current status and future prospects.
    Kakkar AK, Dahiya N.
    Eur J Intern Med; 2015 Mar; 26(2):89-94. PubMed ID: 25634851
    [Abstract] [Full Text] [Related]

  • 2. Obesity Pharmacotherapy.
    Saunders KH, Umashanker D, Igel LI, Kumar RB, Aronne LJ.
    Med Clin North Am; 2018 Jan; 102(1):135-148. PubMed ID: 29156182
    [Abstract] [Full Text] [Related]

  • 3. Long-term effects of weight-reducing drugs in people with hypertension.
    Siebenhofer A, Winterholer S, Jeitler K, Horvath K, Berghold A, Krenn C, Semlitsch T.
    Cochrane Database Syst Rev; 2021 Jan 17; 1(1):CD007654. PubMed ID: 33454957
    [Abstract] [Full Text] [Related]

  • 4. Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events: A Systematic Review and Meta-analysis.
    Khera R, Murad MH, Chandar AK, Dulai PS, Wang Z, Prokop LJ, Loomba R, Camilleri M, Singh S.
    JAMA; 2016 Jun 14; 315(22):2424-34. PubMed ID: 27299618
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Lorcaserin, phentermine topiramate combination, and naltrexone bupropion combination for weight loss: the 15-min challenge to sort these agents out.
    Citrome L.
    Int J Clin Pract; 2014 Dec 14; 68(12):1401-5. PubMed ID: 25418525
    [No Abstract] [Full Text] [Related]

  • 8. Current and emerging pharmacotherapies for obesity in Australia.
    Hocking S, Dear A, Cowley MA.
    Obes Res Clin Pract; 2017 Dec 14; 11(5):501-521. PubMed ID: 28818558
    [Abstract] [Full Text] [Related]

  • 9. Drug treatment of obesity in the cardiovascular patient.
    Charakida M, Tousoulis D, Finer N.
    Curr Opin Cardiol; 2013 Sep 14; 28(5):584-91. PubMed ID: 23928924
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Drug safety evaluation of naltrexone/bupropion for the treatment of obesity.
    Verpeut JL, Bello NT.
    Expert Opin Drug Saf; 2014 Jun 14; 13(6):831-41. PubMed ID: 24766397
    [Abstract] [Full Text] [Related]

  • 13. Nonincretin drugs in later-stage development.
    Zimmerman MP, Mehr SR.
    Am J Manag Care; 2014 Jan 14; 20(1 Spec No.):E2. PubMed ID: 25618226
    [No Abstract] [Full Text] [Related]

  • 14. Pharmacotherapy of Obesity: Clinical Trials to Clinical Practice.
    Gadde KM, Pritham Raj Y.
    Curr Diab Rep; 2017 May 14; 17(5):34. PubMed ID: 28378293
    [Abstract] [Full Text] [Related]

  • 15. Recent advancements in drug treatment of obesity.
    Carter R, Mouralidarane A, Ray S, Soeda J, Oben J.
    Clin Med (Lond); 2012 Oct 14; 12(5):456-60. PubMed ID: 23101148
    [Abstract] [Full Text] [Related]

  • 16. Review of pharmacotherapy options for the management of obesity.
    Bragg R, Crannage E.
    J Am Assoc Nurse Pract; 2016 Feb 14; 28(2):107-15. PubMed ID: 26119641
    [Abstract] [Full Text] [Related]

  • 17. Treatment of obesity in 2015.
    Shukla AP, Buniak WI, Aronne LJ.
    J Cardiopulm Rehabil Prev; 2015 Feb 14; 35(2):81-92. PubMed ID: 25714749
    [Abstract] [Full Text] [Related]

  • 18. A Comparison of New Pharmacological Agents for the Treatment of Obesity.
    Nuffer W, Trujillo JM, Megyeri J.
    Ann Pharmacother; 2016 May 14; 50(5):376-88. PubMed ID: 26887340
    [Abstract] [Full Text] [Related]

  • 19. Formulary management of 2 new agents: lorcaserin and phentermine/topiramate for weight loss.
    Kelly EM, Tungol AA, Wesolowicz LA.
    J Manag Care Pharm; 2013 Oct 14; 19(8):642-54. PubMed ID: 24074010
    [Abstract] [Full Text] [Related]

  • 20. Fixed-dose combination of phentermine-topiramate for the treatment of obesity.
    Halpern B, Faria AM, Halpern A.
    Expert Rev Clin Pharmacol; 2013 May 14; 6(3):235-41. PubMed ID: 23656337
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.